logo

JAZZ

Jazz Pharmaceuticals·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

JAZZ fundamentals

Jazz Pharmaceuticals (JAZZ) released its earnings on Nov 5, 2025: revenue was 1.13B (YoY +6.60%), beat estimates; EPS was 8.13 (YoY +23.00%), beat estimates.
Revenue / YoY
1.13B
+6.60%
EPS / YoY
8.13
+23.00%
Report date
Nov 5, 2025
JAZZ Earnings Call Summary for Q3,2025
  • Revenue Record: Q3 2025 revenue of $1.126B (+7% YoY), driven by sleep, epilepsy, and oncology growth.
  • FDA Wins: Zepzelca first-line approval and Modeyso launch highlight regulatory momentum.
  • Pipeline Catalysts: Zanidatamab GEA data due Q4, Kv7 epilepsy deal expands early-stage pipeline.
  • Generic Risk: 2026 Xyrem generics expected, but Xywav's low-sodium differentiation and Hikma royalties mitigate impact.
  • Financial Strength: $2B cash, narrowed 2025 guidance to $4.175B–$4.275B, and strong cash flow support growth.
EPS
Revenue

Revenue & Expenses

JAZZ has released its 2025 Q3 earnings report, with revenue of 1.13B, reflecting a YoY change of 6.74%, and net profit of 251.41M, showing a YoY change of 16.91%. The Sankey diagram below clearly presents JAZZ's revenue sources and cost distribution.

Key Indicators

Jazz Pharmaceuticals (JAZZ) key financial stats and ratios, covering profitability, financial health, and leverage.
Jazz Pharmaceuticals (JAZZ)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Jazz Pharmaceuticals (JAZZ)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Jazz Pharmaceuticals (JAZZ)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Jazz Pharmaceuticals (JAZZ) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Jazz Pharmaceuticals (JAZZ) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield